Search - tctmd.com

Displaying 401 - 420 of 643

Sort: Relevancy | Date

Presentation TCT 2016

Introduction to the TCT 2016 Peripheral Vascular Intervention Sessions

Presenter: D. Christopher Metzger, Constantino S. Pena, Michael R. Jaff

October 30, 2016

Presentation TCT 2016

TCT 375: Renal Impairment is Primarily Caused by Patient and Procedural Complexity Nationwide Study of Acute Kidney Injury Following Coronary Angiography and Intervention

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

TCT 374: Propensity Score Matched Analysis of Acute Kidney Injury Following Percutenous Coronary Intervention with Trans-Radial versus Trans-Femoral Approach

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Presenter: Joseph P. Carrozza Jr, Charles J. Davidson

October 30, 2016

Presentation TCT 2016

Using Virtual Reality in Interventional Cardiology

Presenter: Oscar A. Mendiz, Giora Weisz, Silvio J. Bezerra

October 30, 2016

Presentation TCT 2016

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Presenter: Oscar A. Mendiz, Giora Weisz, Caterina Gandolfo

October 30, 2016

Presentation TCT 2016

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

Presenter: Oscar A. Mendiz, Giora Weisz, Philipp Lurz

October 30, 2016

Presentation TCT 2016

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Presenter: Oscar A. Mendiz, Giora Weisz, Horst Sievert

October 30, 2016

Presentation TCT 2015

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

October 15, 2015

Presentation TCT 2015

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

Presenter: Greg L. Kaluza, Joachim Schofer, Richard R. Heuser

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

Presenter: Gerhard C. Schuler, C. Michael Gibson

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

Presenter: Michael A. Weber, Stephen G. Worthley, Konstantinos Tsioufis

October 13, 2015

Presentation TCT 2015

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

Presenter: Michael A. Weber, Stephen G. Worthley, Ole Mathiassen

October 13, 2015

Presentation TCT 2015

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

Presenter: Michael A. Weber, Stephen G. Worthley, Tim A. Fischell

October 13, 2015

Presentation TCT 2015

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder

October 13, 2015

Presentation TCT 2015

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

Presenter: Michael A. Weber, Stephen G. Worthley

October 13, 2015

Presentation TCT 2015

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

Presenter: Jeffrey J. Popma, Mathew Williams, Nirat Beohar

October 13, 2015

Presentation TCT 2015

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

Presenter: Michael A. Weber, Stephen G. Worthley, Melvin D. Lobo

October 13, 2015

Advertisement

Introduction to the TCT 2016 Peripheral Vascular Intervention Sessions

TCT 375: Renal Impairment is Primarily Caused by Patient and Procedural Complexity Nationwide Study of Acute Kidney Injury Following Coronary Angiography and Intervention

TCT 374: Propensity Score Matched Analysis of Acute Kidney Injury Following Percutenous Coronary Intervention with Trans-Radial versus Trans-Femoral Approach

TCT 546: Imaging and Physiology-Guided Zero Contrast Percutaneous Coronary Intervention in Advanced Chronic Kidney Disease

Using Virtual Reality in Interventional Cardiology

A Percutaneous Shoehorn via Transbrachial Artery Approach in a Staggering Tavi Procedure With Edwards Sapien 3 Aortic Valve in a Patient With Extremely Calcified Aortic Valve

Peri-Procedural Planning of Renal Sympathetic Denervation using the ReCor Paradise System

LV Volume Reduction in Post-AMI, Ischemic Heart Failure Patients

Contrast Nephropathy Clinical Trial Updates (AVERT, RenalGuard, Preserve, and Others)

Featured Vascular Innovation Technologies 5: Denervation in Hypertensive Renal Transplantation Patients Verves Disruptive Nonvascular Catheter Option to Nephrectomy

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Considerations Regarding Renal Function in the Patient With Atrial Fibrillation

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study

TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial)

TCT 88: Transcatheter Perivascular Chemical Neurolysis to Produce Renal Denervation Targeted, Local Delivery of Alcohol as a Viable Alternative to Radiofrequency Approaches

TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results

TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study

TCT 93: Improvement in Renal Function and Its Impact on All-Cause Mortality After Transcatheter Aortic Valve Replacement (TAVR) Experience From the PARTNER Trial

TCT 85: Safety and Performance of the EnligHTN Renal Denervation System in Patients With Severe Uncontrolled Hypertension Twelve-Month Results From the EnligHTN II Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content